|
ECT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.080200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.361870E-02 |
| Normal-vs-Stage2 |
6.694800E-01 |
| Normal-vs-Stage3 |
1.215630E-02 |
| Normal-vs-Stage4 |
1.362400E-02 |
| Stage1-vs-Stage2 |
2.288400E-02 |
| Stage1-vs-Stage3 |
4.687000E-01 |
| Stage1-vs-Stage4 |
2.031000E-01 |
| Stage2-vs-Stage3 |
1.029850E-02 |
| Stage2-vs-Stage4 |
9.823600E-03 |
| Stage3-vs-Stage4 |
5.640000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.643300E-03 |
| Normal-vs-AfricanAmerican |
3.283900E-02 |
| Normal-vs-Asian |
2.371800E-01 |
| Caucasian-vs-AfricanAmerican |
5.235600E-01 |
| Caucasian-vs-Asian |
3.295400E-01 |
| AfricanAmerican-vs-Asian |
1.870190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.822300E-02 |
| Normal-vs-Female |
8.581800E-03 |
| Male-vs-Female |
8.436800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.398800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.582200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.180300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.249500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.759880E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.278600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.100200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.801580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.782200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.802100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.432200E-02 |
| Classical-VS-Follicular |
1.33350000042221E-07 |
| Classical-VS-Other |
3.113000E-01 |
| Classical-VS-Normal |
3.774100E-04 |
| Tall-VS-Follicular |
6.31359999999637E-05 |
| Tall-VS-Other |
9.648200E-02 |
| Tall-VS-Normal |
9.559800E-04 |
| Follicular-VS-Other |
4.552000E-01 |
| Follicular-VS-Normal |
1.709820E-01 |
| Other-VS-Normal |
8.603600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.353000E-01 |
| Normal-vs-N1 |
1.742430E-01 |
| N0-vs-N1 |
2.827200E-01 |
|
|
